- Eli Lilly shares surged more than 5% in pre-market trading; second-quarter revenue reached $22.974 billions, up 48% year-on-year; adjusted earnings per share stood at $8.38, marking a 33% year-on-year increase.
- German 10-year government bond yields hit a three-week low as expectations of a Hormuz Strait agreement weighed on oil prices and rate hike bets.
- Spot platinum has just broken through the $1,740.00/oz mark, currently quoted at $1,739.98/oz, up 0.41% on the day; Nymex main platinum futures are currently quoted at $1,757.2/oz, up 0.07% on the day.
- Uber Technologies: 3Q Gross Bookings Outlook Assumes Roughly 1 Percentage-Point Currency Headwind to Total Reported YoY Growth >UBER
- Uber Technologies: Added More First-Time Users in Past 12 Months Than in Any Period Over Past Five Years >UBER
- Uber Technologies 2Q Adjusted Ebitda $2.8B >UBER
- Uber Technologies 2Q Gross Bookings Up 22% on Constant-Currency Basis >UBER
- Uber Technologies 2Q Trips 3.87B >UBER
- Uber Technologies 2Q Gross Bookings Up 24% >UBER
- Uber Technologies 2Q Freight Gross Bookings $1.57B >UBER
- Uber Technologies 2Q Gross Bookings $58.02B >UBER
- Uber Technologies 2Q Rev $14.19B >UBER
- Uber Technologies 2Q Adj EPS 81c >UBER
- AMGEN INC : LEERINK PARTNERS RAISES TARGET PRICE TO $395 FROM $355
- Vin's Holdings expects marginal 1H2026 net profit, versus loss a year earlier
- Infosys expands strategic partnership with Finland’s Metsä Group to accelerate AI-led IT transformation
- HUT 8 CORP <HUT.O>: CLEAR STREET RAISES TARGET PRICE TO $170 FROM $148
- Kontoor Brands agrees to sell Lee business to Authentic Brands affiliate ABG-Storm LLC
- ADDUS HOMECARE CORP : BMO RAISES TARGET PRICE TO $115 FROM $110
- Materion FY26 Q2 net income rises 55% to $38.8 million; net sales climb 42% to $613.9 million
- Disney (DIS.US): Still predicts full-year capital expenditure of $9 billion (market estimate: $8.88 billion).
- Eton Pharmaceuticals licenses US rights to Auson’s ASN-001 for infantile hemangiomas
- Bitcoin ETFs log inflows as cold wallet hack reignites custody debate
- WAYFAIR INC. <W.N>: BMO RAISES TARGET PRICE TO $115 FROM $105
- Mainstreet Equity FY26 Q3 FFO rises 9% to $26.4 million; net profit falls 28% to $33.7 million
- Protalix BioTherapeutics to report Q2 results, host conference call and webcast
- SUNCOR ENERGY INC (CANADA) <SU.TO>: BMO RAISES TARGET PRICE TO C$105 FROM C$100
- CMC targets FY29 core EBITDA of $1.65 billion-$1.8 billion
- SYSCO <SYY.N>: BMO RAISES TARGET PRICE TO $98 FROM $90
- Eli Lilly Raises FY View To Rev $85B-$87B >LLY
- Eli Lilly 2Q Revenue Outside the U.S. Increased 80% to $8.6 B >LLY
- Eli Lilly Q2 FY26 EPS rises 26% to $7.94; revenue increases 48% to $23 billion
- Cencora ups multi-currency revolving credit facility to $7 billion, extends maturity to July 2031
- BorgWarner forecasts 2026 net sales of $14 billion-$14.3 billion
- Chimera Q2 FY26 turns to GAAP net loss of USD 4 million; earnings available for distribution slips to USD 39 million
- Circle names BlackRock, Mastercard, Visa as initial Arc validators ahead of Sept. 16 mainnet
- AMETEK : BMO RAISES TARGET PRICE TO $282 FROM $262
- Iron Mountain Q2 FY26 net income turns to profit at USD 106.1 million; revenue rises 18.5% to USD 2.03 billion
- BRIEF-Materion Q2 Operating Profit USD 51.7 Million
- Capri Q1 FY27 EPS rises to $0.60; revenue drops 3.5% to $769 million
- Eos Energy Q2 net loss widens to $275.7 million; revenue rises 351% to $68.8 million
- TOAST, INC. <TOST.N>: BMO RAISES TARGET PRICE TO $40 FROM $35
- TRAVERE THERAPEUTICS, INC. <TVTX.O>: CITIGROUP RAISES TARGET PRICE TO $85 FROM $70
- Eos Energy Enterprises 2Q Rev $68.8M >EOSE
- Eos Energy Enterprises 2Q Loss $406.3M >EOSE
- Eos Energy Enterprises 2Q Loss/Shr $1.20 >EOSE
- Materion Sees FY Adj EPS $6.80-Adj EPS $7.20 >MTRN
- Materion 2Q EPS $1.84 >MTRN
- Materion 2Q Sales $613.9M >MTRN
- Materion 2Q Net $38.8M >MTRN
- AMGEN INC : BMO RAISES TARGET PRICE TO $450 FROM $400
- PINTEREST : BMO RAISES TARGET PRICE TO $34 FROM $30
- CMC boosts share buyback authorization by $600 million to about $717 million
- Adient FY26 Q3 adjusted EBITDA slips to $225 million; revenue rises 5% to about $3.9 billion
- BRIEF-Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01
- BRIEF-Iron Mountain Q2 Adjusted EPS USD 0.6 Vs. IBES Estimate USD 0.56
- BOOKING HOLDINGS INC. <BKNG.O>: BMO RAISES TARGET PRICE TO $250 FROM $240
- Target Hospitality names Margaret Smyth, Erich Sanchack as independent directors
- Sally Beauty to present at Canaccord Genuity Annual Growth Conference
- PAYLOCITY HOLDING CORP : BMO RAISES TARGET PRICE TO $175 FROM $143
- Chimera declares Q3 2026 Series A preferred dividend of $0.5 a share
- Ternium books $71.5 million charge tied to Usiminas litigation in Brazil
- Eli Lilly 2Q Rev $22.97B >LLY
- Iron Mountain 2Q Adj EPS 60c >IRM
- Iron Mountain Sees FY Rev $7.94B-$8.01B >IRM
- Iron Mountain 2Q Adjusted FFO/Shr $1.44 >IRM
- Major Canadian Economic Indicators Expected This Week
- Iron Mountain 2Q EPS 34c >IRM
- Iron Mountain 2Q Net $101.4M >IRM
- Iron Mountain 2Q FFO 76c/Shr >IRM
- Chimera Investment 2Q Loss/Shr 5c >CIM
- Chimera Investment 2Q Adj EPS 46c >CIM
- Eli Lilly Sees FY Rev $85B-$87B >LLY
- Eli Lilly 2Q EPS $7.94 >LLY
- Eli Lilly 2Q Adj EPS $8.38 >LLY
- Eli Lilly 2Q Net $7.1B >LLY
- Eli Lilly 2Q Zepbound Rev $4.93B >LLY
- Iron Mountain 2Q Rev $2B >IRM
- GARTNER <IT.N>: BMO RAISES TARGET PRICE TO $214 FROM $154
- WYNN RESORTS, LIMITED <WYNN.O>: MIZUHO RAISES TARGET PRICE TO $132 FROM $125
- PROGRESSIVE CORP : MIZUHO CUTS TARGET PRICE TO $236 FROM $243
- MCDONALD'S <MCD.N>: BMO CUTS TARGET PRICE TO $335 FROM $360
- MOSAIC CO <MOS.N>: MIZUHO RAISES TARGET PRICE TO $25 FROM $24
- Thomson Reuters Raises 2026 Growth to 8% >TRI
- PINTEREST : MIZUHO RAISES TARGET PRICE TO $32 FROM $31
- ADM : BMO RAISES TARGET PRICE TO $82 FROM $77
- PAYLOCITY HOLDING CORP : MIZUHO RAISES TARGET PRICE TO $180 FROM $150
- HENRY SCHEIN, INC. <HSIC.O>: MIZUHO RAISES TARGET PRICE TO $86 FROM $82
- FIS <FIS.N>: MIZUHO CUTS TARGET PRICE TO $60 FROM $66
- ENTEGRIS INC <ENTG.O>: MIZUHO CUTS TARGET PRICE TO $185 FROM $200
- BP <BP.N>: WELLS FARGO CUTS TARGET PRICE TO $48 FROM $54
- DUKE ENERGY CORP <DUK.N>: MIZUHO RAISES TARGET PRICE TO $136 FROM $135
- Tesmec swings to 1H FY26 net profit of EUR 4.5 million; revenue rises 12.2% to EUR 144.2 million
- BOOKING HOLDINGS INC. <BKNG.O>: MIZUHO RAISES TARGET PRICE TO $240 FROM $220
- Canada Packers 2Q Adj EPS C$0.34 >CPKR.T
- Cardinal Health appoints Anita Zielinski as chief accounting officer effective Nov. 5
- BP <BP.N>: MIZUHO RAISES TARGET PRICE TO $53 FROM $51
- OUE REIT to hold SIAS dialogue session on S$500 million Crowne Plaza Changi Airport divestment
- Nurix CSO Gwenn Hansen sells 4,111 shares for $100,068.32
- Canada Packers 2Q Sales C$431.7M >CPKR.T
